Kelun - Public Comps and Valuation Multiples

Kelun Overview

About Kelun

Sichuan Kelun Pharmaceutical Co Ltd is a China-based pharmaceutical company focused on the manufacturing of infusion products, antibiotics, and various medical devices. The company operates its businesses through three segments. The Twinings segment focuses on producing pharmaceutical intermediates. The Botai segment is dedicated to the research, development, manufacturing, and commercialization of medicines. The Other Business segment covers activities such as the development and production of large-volume injections, along with the research, manufacturing, and sales of additional pharmaceutical products and related businesses.

Founded

2002

HQ

Employees

21.9K+

Website

kelun.com

Sectors

Drug Development & Therapeutics
Medical Supplies
BioTech

Financials

LTM Revenue $2.8B

LTM EBITDA $627M

EV

$7.3B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Kelun Financials

As of September 2025, Kelun reported last 12-month revenue of $2.8B and EBITDA of $627M.

In the same period, Kelun generated $1.3B in LTM gross profit and $359M in net income.

See Kelun valuation multiples based on analyst estimates

Kelun P&L

In the most recent fiscal year, Kelun reported revenue of $3.1B and EBITDA of $802M.

Kelun expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Kelun valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$2.8B	XXX	$3.1B	XXX	XXX	XXX
Gross Profit	$1.3B	XXX	$1.6B	XXX	XXX	XXX
Gross Margin	47%	XXX	52%	XXX	XXX	XXX
EBITDA	$627M	XXX	$802M	XXX	XXX	XXX
EBITDA Margin	22%	XXX	26%	XXX	XXX	XXX
EBIT	$473M	XXX	$612M	XXX	XXX	XXX
EBIT Margin	17%	XXX	20%	XXX	XXX	XXX
Net Profit	$359M	XXX	$412M	XXX	XXX	XXX
Net Margin	13%	XXX	13%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Kelun including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $2.8B. EBITDA for the last twelve months was $627M. In the most recent fiscal year, Kelun achieved $3.1B in revenue and $802M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$2.8B	Analyst estimates available to subscribers	$3.1B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$1.3B	Analyst estimates available to subscribers	$1.6B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	47.4% gross margin	Analyst estimates available to subscribers	51.7% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$627M	Analyst estimates available to subscribers	$802M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	22.3% EBITDA margin	Analyst estimates available to subscribers	26.2% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$473M	Analyst estimates available to subscribers	$612M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	16.8% EBIT margin	Analyst estimates available to subscribers	20.0% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$359M	Analyst estimates available to subscribers	$412M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	12.8% net profit margin	Analyst estimates available to subscribers	13.5% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Kelun

This financial data table provides comprehensive performance metrics for Kelun, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Kelun generated $2.8B in revenue over the last twelve months.
The company achieved $627M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $1.3B.
Net income over the last twelve months reached $359M.

Fiscal Year Performance

In the most recent fiscal year, Kelun reported $3.1B in total revenue.
Fiscal year EBITDA was $802M.
The company maintained a gross profit margin of 51.7% in the most recent fiscal year.
EBITDA margin for the fiscal year was 26.2%.
Net profit margin reached 13.5% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Kelun. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Kelun Stock Performance

Kelun has current market cap of CNY 54.3B (or $7.6B), and EV of CNY 52.0B (or $7.3B).

Market Cap Evolution

Kelun Stock Data

As of October 15, 2025, Kelun's stock price is CNY 34 (or $5).

See Kelun trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$7.3B	$7.6B	XXX	XXX	XXX	XXX	$0.22

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Kelun Valuation Multiples

Kelun's trades at 2.4x EV/Revenue multiple, and 9.1x EV/EBITDA.

See valuation multiples for Kelun and 15K+ public comps

Kelun Financial Valuation Multiples

As of October 15, 2025, Kelun has market cap of $7.6B and EV of $7.3B.

Equity research analysts estimate Kelun's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Kelun has a P/E ratio of 21.2x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$7.6B	XXX	$7.6B	XXX	XXX	XXX
EV (current)	$7.3B	XXX	$7.3B	XXX	XXX	XXX
EV/Revenue	2.6x	XXX	2.4x	XXX	XXX	XXX
EV/EBITDA	11.6x	XXX	9.1x	XXX	XXX	XXX
EV/EBIT	15.4x	XXX	11.9x	XXX	XXX	XXX
EV/Gross Profit	5.5x	XXX	n/a	XXX	XXX	XXX
P/E	21.2x	XXX	18.5x	XXX	XXX	XXX
EV/FCF	n/a	XXX	18.5x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Kelun Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Kelun Margins & Growth Rates

Kelun's last 12 month revenue growth is 3%

Kelun's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $44K for the same period.

Kelun's rule of 40 is 28% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Kelun's rule of X is 31% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Kelun and other 15K+ public comps

Kelun Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	3%	XXX	-2%	XXX	XXX	XXX
EBITDA Margin	22%	XXX	26%	XXX	XXX	XXX
EBITDA Growth	4%	XXX	-9%	XXX	XXX	XXX
Rule of 40	28%	XXX	30%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	31%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$44K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	16%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	10%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	32%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial